Throat Remedy
NDC 85946-0002, Belladonna 30C, Hear sulphuris calcareum 30C, Lachesis mutus 30C, Mercurius solubilis 30C, Phytolacca decandra 30C, Ferrum phosphoricum 6X, Kali muriaticum 5X, Calcarea sulphurica 6X, Streptococcinum 200C, pellet, from JoyWell Co LLC.
- Product NDC
- 85946-0002
- Status
- Listed
- Labeler
- JoyWell Co LLC
- Dosage form
- PELLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85946-0002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATROPA BELLADONNA30 [hp_C]/1
- CALCIUM SULFIDE30 [hp_C]/1
- LACHESIS MUTA VENOM30 [hp_C]/1
- MERCUROUS NITRATE30 [hp_C]/1
- PHYTOLACCA AMERICANA ROOT30 [hp_C]/1
- FERRIC PHOSPHATE6 [hp_X]/1
- POTASSIUM CHLORIDE5 [hp_X]/1
- CALCIUM SULFATE, UNSPECIFIED FORM6 [hp_X]/1
- STREPTOCOCCUS PYOGENES200 [hp_C]/1
Pharmacologic classes
Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Iron [CS]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Parenteral Iron Replacement [EPC]; Phosphate Binder [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85946-0002-1 | 85946000201 | 100 PELLET in 1 VIAL (85946-0002-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 85946-0002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85946-0002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85946-0002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.